Bioprocess Engineering in
Plasma-Derived Biopharmaceuticals
Nojin Biopharma, as a pioneer in the biological pharmaceutical industry, integrates Class A cleanroom quality control with advanced molecular separation technologies, committing to elevate the national capacity of human plasma-derived biopharmaceuticals.
The largest nominal blood plasma fractionation capacity in the country, powered by modern phase-separation technology.
Production of life-saving immunoglobulins, albumin, and coagulation factors relying on indigenous biotechnology.
Continuous development of purification processes in collaboration with national biopharma experts and medical doctors.
Implementation of advanced nanofiltration methods and multi-step pathogen inactivation.
Nojin Biological Products Portfolio
Scientific monographs, clinical data, and specifications of human plasma-derived biopharmaceuticals.
IMMUnojine ® 5%
IVIG 50 mg/mL solution for infusion - Human normal immunoglobulin (IVIG)
Human Normal Immunoglobulin for Intravenous Administration (IVIG) ۵%.
Main Indications
Used as replacement therapy in Primary and Secondary Immunodeficiency syndromes, and autoimmune conditions.
ALBUJINE® 20%
Albujin 20% - Solution for infusion Human Serum (HSA)
Albumin is the most abundant plasma protein, responsible for maintaining ۷۰% to ۸۰% of the intravascular colloid osmotic pressure.
Main Indications
Indicated for volume expansion and maintenance of cardiac output in the treatment of hypovolemic shock.
Advancing Self-Sufficiency in Biopharmaceutical Production
Our focus is on patient safety, high formulation standards, and continuous research and development.
Scientific Innovation
Utilizing advanced bioprocesses for recombinant drug formulation.
National Self-Sufficiency
Reducing international dependency in human plasma-derived biopharmaceuticals production.
Global GMP Standards
Adherence to the strictest World Health Organization guidelines in cleanrooms.
Latest Scientific Achievements
Strategic Collaboration Agreement Signed Between Nojine Zist Pharmed and Pasteur Institute of Iran
A landmark memorandum of understanding for joint biotechnology research and development of specialized immunoglobulin formulations was officially signed.
Nojine Achieves 100% Pharmacopoeial Compliance Under WHO-GMP Biological Standards
Periodic regulatory and healthcare audits concluded with outstanding scores and zero deviations, affirming Nojin's commitment to world-class aseptic manufacturing.
Nojine Scientists Present Breakthrough Clinical Research at 25th International Congress of Pharmaceutical Biotechnology
Presentation of three prominent research papers regarding efficacy optimization of Albojin in intensive care units received accolades from international scientific panels.
Nojine Upgrades Cold Chain Supply Infrastructure with Smart IoT and Cloud Telemetry Sensors
Ensuring uncompromising 2°C to 8°C thermal stability from production lines to nationwide clinical centers via real-time GPS telemetry and cloud logging.
Have a Question? Find the Answer with
Our Scientific Experts
In this section, we have endeavored to answer your frequently asked questions about the plasma fractionation process, GMP biosafety requirements, and strategic cold chain logistics in the most scientific manner.
Human plasma enters the production chain of plasma-derived drugs under advanced screening processes, enrichment, and continuous genetic monitoring to achieve maximum purity and safe biological efficacy.
All production processes are conducted under the strict supervision of the Food and Drug Administration (IFDA) and in compliance with the latest World Health Organization (WHO-GMP) protocols to guarantee product safety.
Requests for single-prescription biological medications can be tracked through nojine’s integrated supply system following approval by the company’s medical and scientific committee.
Yes, our Research and Development (R&D) department maintains deep ties with top-tier national medical universities in line with localizing modern plasma fractionation technologies.
All pharmaceutical vials possess a unique tracking code (UID) connected to the FDA TTAC system, which instantly verifies the product’s authenticity.
We utilize a specialized logistics fleet equipped with smart monitoring and electronic temperature logging to ensure products reach medical centers precisely between 2 and 8 degrees Celsius without any fluctuation.